NCT02336360View on ClinicalTrials.gov

Augmenting Flortaucipir Dosimetry Estimates

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Alzheimer's Disease
Interventions
DRUG

Flortaucipir F18

No flortaucipir administered in this study. Subjects received flortaucipir in an Avid-sponsored study.

Trial Locations (1)

06510

Molecular NeuroImaging, New Haven

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY